SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY ARTICLE L impact

Aclaris Therapeutics to participate in Sept. 10 Cantor healthcare conference

Aclaris Therapeutics said its Chief Exec officer will present at the 2026 Cantor Global Healthcare Conference on Thursday, Sept. 10, 2026 at 2:45 PM ET.

ACRS

WAYNE, Pa., Sept.

03, 2026 (GLOBE NEWSWIRE) -- Aclaris Therapeutics, Inc.

NASDAQ:ACRS, a clinical-stage biopharmaceutical company focused on developing novel product candidates for immuno-inflammatory diseases, today announced that on Thursday, September 10, 2026, at 2:45 PM ET, Aclaris’ Chief Exec…